A 28-year-old woman presents with persistent low mood, anhedonia, and impaired functioning for 8 weeks. There is no bipolar history, psychosis, or substance misuse. She has not previously received treatment. According to CANMAT 2023 guidelines, what is an appropriate first-line pharmacologic treatment option for major depressive disorder?